Mutant p53 gain of function induces HER2 over-expression in cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutant p53 gain of function induces HER2 over-expression in cancer cells
Authors
Keywords
HER2, Mutant p53, Gain of function, Cancer
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-03
DOI
10.1186/s12885-018-4613-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis
- (2015) Alisha R. Yallowitz et al. MOLECULAR CANCER RESEARCH
- Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
- (2015) Jiajun Zhu et al. NATURE
- Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites
- (2015) Catherine A. Vaughan et al. Oncotarget
- HER2 aberrations in cancer: Implications for therapy
- (2014) Min Yan et al. CANCER TREATMENT REVIEWS
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress
- (2014) D Li et al. Cell Death & Disease
- Tumor suppressor p53 and its gain-of-function mutants in cancer
- (2013) J. Liu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Towards Sustained Silencing of HER2/neu in Cancer By Epigenetic Editing
- (2013) F. Falahi et al. MOLECULAR CANCER RESEARCH
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
- (2010) I Goldstein et al. CANCER GENE THERAPY
- Modulation of apoptosis by early human papillomavirus proteins in cervical cancer
- (2009) A. Lagunas-Martínez et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Cell Lines as Candidate Reference Materials for Quality Control of ERBB2 Amplification and Expression Assays in Breast Cancer
- (2009) Y. Xiao et al. CLINICAL CHEMISTRY
- A Negative Feedback Regulatory Loop Associates the Tyrosine Kinase Receptor ERBB2 and the Transcription Factor GATA4 in Breast Cancer Cells
- (2009) G. Hua et al. MOLECULAR CANCER RESEARCH
- Unraveling the Biologic and Clinical Complexities of HER2
- (2008) John W. Park et al. Clinical Breast Cancer
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now